Pulmonary hypertension (PH) affects> 25 million individuals worldwide and causes
premature disability and death for many. The diagnosis and treatment of PH have advanced …

An expert committee representing multiple disciplines has developed “Diagnosis and
Management of Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice …

The field of pulmonary hypertension (PH) has evolved and expanded tremendously since
the 1990s in conjunction with greater understanding of the condition, better appreciation of …

Pulmonary hypertension (PH) is a chronic, progressive, life-threatening disease that
requires expert multidisciplinary care. To facilitate this level of care, the Pulmonary …

During the past 2 decades, there has been a tremendous evolution in the evaluation and
care of patients with pulmonary arterial hypertension (PAH). The introduction of targeted …

The Canadian Cardiovascular Society and the Canadian Thoracic Society requested a
position statement on pulmonary arterial hypertension from leading Canadian experts. The …

We conducted an international study to evaluate practices in the diagnosis and
management of pulmonary arterial hypertension (PAH) globally across different geographic …

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension | Circulation Science
Volunteer Warning signs SearchSearch Advanced Search Donate Circulation logo Hello Guest …

Interposed between the two sides of the heart and embedded within the matrix of the lung,
the pulmonary circulation plays a pivotal role in the cardiopulmonary functions of gas …

Pulmonary hypertension (PH) is common, with an estimated prevalence of approximately
1% that increases with age. Prompt and accurate diagnosis is key to institute timely and …